InsiderTrades.com logo

URGN Insider Trading

Insider Ownership Percentage: 4.70%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,082,715.32

Urogen Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at Urogen Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Urogen Pharma Share Price & Price History

Current Price: $17.90
Price Change: ▼ Price Decrease of -0.22 (-1.21%)
As of 03/26/2026 05:00 PM ET

This chart shows the closing price history over time for URGN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Urogen Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/3/2026Jason Drew SmithGeneral CounselSell7,479$19.69$147,261.5151,326View SEC Filing Icon  
2/3/2026Mark SchoenbergInsiderSell7,373$19.69$145,174.37144,985View SEC Filing Icon  
11/19/2025Mark SchoenbergInsiderSell10,000$25.00$250,000.00139,025View SEC Filing Icon  
10/8/2025Chris DegnanCFOSell2,203$16.85$37,120.552,280View SEC Filing Icon  
9/8/2025Jason Drew SmithGeneral CounselSell1,520$19.11$29,047.2043,305View SEC Filing Icon  
9/8/2025Mark SchoenbergInsiderSell871$19.11$16,644.81149,025View SEC Filing Icon  
8/11/2025Mark SchoenbergInsiderSell10,000$17.69$176,900.00148,229View SEC Filing Icon  
7/28/2025Jason Drew SmithGeneral CounselSell7,522$19.14$143,971.0841,492View SEC Filing Icon  
7/28/2025Mark SchoenbergInsiderSell5,149$19.14$98,551.86158,229View SEC Filing Icon  
6/9/2025Mark SchoenbergInsiderSell5,162$7.37$38,043.94153,378View SEC Filing Icon  
1/31/2025Jason Drew SmithGeneral CounselSell7,379$11.14$82,202.0626,468View SEC Filing Icon  
1/31/2025Mark SchoenbergInsiderSell4,551$11.14$50,698.14145,666View SEC Filing Icon  
9/9/2024Jason Drew SmithGeneral CounselSell1,521$13.08$19,894.6825,226View SEC Filing Icon  
9/9/2024Mark SchoenbergInsiderSell859$13.08$11,235.72145,091View SEC Filing Icon  
6/10/2024Mark SchoenbergInsiderSell5,153$13.08$67,401.24144,284View SEC Filing Icon  
3/18/2024Mark SchoenbergInsiderSell12,000$14.05$168,600.00139,437View SEC Filing Icon  
1/31/2024Jason Drew SmithGeneral CounselSell4,993$15.74$78,589.8218,824View SEC Filing Icon  
1/31/2024Mark SchoenbergInsiderSell3,789$15.74$59,638.86149,423View SEC Filing Icon  
8/31/2023Jason Drew SmithGeneral CounselSell3,800$18.01$68,438.0018,407View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Urogen Pharma (NASDAQ:URGN)

91.29% of Urogen Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at URGN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Urogen Pharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/20/2026Hsbc Holdings PLC10,316$0.24M0.0%-25.7%0.021%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.27,066$0.63M0.0%+21.1%0.058%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd22,491$0.53M0.0%-23.2%0.048%Search for SEC Filing on Google Icon
2/18/2026Voloridge Investment Management LLC435,490$10.20M0.0%-36.7%0.930%Search for SEC Filing on Google Icon
2/18/2026Susquehanna Portfolio Strategies LLC27,380$0.64M0.0%N/A0.058%Search for SEC Filing on Google Icon
2/18/2026Tang Capital Management LLC350,000$8.20M0.4%-65.0%0.748%Search for SEC Filing on Google Icon
2/18/2026Superstring Capital Management LP718,354$16.82M9.0%+717.1%1.535%Search for SEC Filing on Google Icon
2/18/2026Orbimed Advisors LLC875,487$20.50M0.4%+27.1%1.870%Search for SEC Filing on Google Icon
2/18/2026Opaleye Management Inc.268,423$6.29M0.8%N/A0.573%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC618,952$14.50M0.0%-59.1%1.322%Search for SEC Filing on Google Icon
2/18/2026Main Street Financial Solutions LLC20,990$0.49M0.0%-34.8%0.045%Search for SEC Filing on Google Icon
2/18/2026Elmind Capital LP100,000$2.34M0.7%N/A0.214%Search for SEC Filing on Google Icon
2/18/2026Cinctive Capital Management LP16,991$0.40M0.0%N/A0.036%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC153,413$3.59M0.0%-24.9%0.328%Search for SEC Filing on Google Icon
2/17/2026Cetera Investment Advisers30,096$0.71M0.0%-6.2%0.064%Search for SEC Filing on Google Icon
2/17/2026MPM Bioimpact LLC941,378$22.05M2.5%+597.3%2.011%Search for SEC Filing on Google Icon
2/17/2026Paradigm Biocapital Advisors LP4,473,648$104.77M2.7%+6.1%9.557%Search for SEC Filing on Google Icon
2/17/2026Jump Financial LLC17,900$0.42M0.0%-82.8%0.038%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD616,606$14.44M0.0%+72.9%1.317%Search for SEC Filing on Google Icon
2/17/2026Diadema Partners LP21,810$0.51M0.1%-75.8%0.047%Search for SEC Filing on Google Icon
2/17/2026Russell Investments Group Ltd.47,257$1.11M0.0%+1,323.0%0.101%Search for SEC Filing on Google Icon
2/17/2026Atom Investors LP234,423$5.49M0.4%-19.7%0.501%Search for SEC Filing on Google Icon
2/17/2026ExodusPoint Capital Management LP35,393$0.83M0.0%+113.9%0.076%Search for SEC Filing on Google Icon
2/17/2026Royal Bank of Canada8,391$0.20M0.0%-81.5%0.018%Search for SEC Filing on Google Icon
2/17/2026Persistent Asset Partners Ltd12,806$0.30M0.1%-38.2%0.027%Search for SEC Filing on Google Icon
2/17/2026Rice Hall James & Associates LLC281,876$6.60M0.4%+8.8%0.602%Search for SEC Filing on Google Icon
2/16/2026Squarepoint Ops LLC22,831$0.54M0.0%N/A0.049%Search for SEC Filing on Google Icon
2/16/2026Panagora Asset Management Inc.74,055$1.73M0.0%-59.8%0.158%Search for SEC Filing on Google Icon
2/16/2026MML Investors Services LLC24,363$0.57M0.0%N/A0.052%Search for SEC Filing on Google Icon
2/16/2026Healthcare of Ontario Pension Plan Trust Fund1,125,100$26.35M0.0%N/A2.404%Search for SEC Filing on Google Icon
2/16/2026Barclays PLC57,744$1.35M0.0%+3.8%0.123%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP16,300$0.38M0.0%-12.7%0.035%Search for SEC Filing on Google Icon
2/13/2026The Manufacturers Life Insurance Company 55,686$1.29M0.0%+55.0%0.119%Search for SEC Filing on Google Icon
2/13/2026Morgan Stanley2,562,901$60.02M0.0%+1.4%5.475%Search for SEC Filing on Google Icon
2/13/2026State Street Corp807,421$18.91M0.0%-1.5%1.725%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN84,158$1.97M0.0%-33.2%0.180%Search for SEC Filing on Google Icon
2/12/2026HRT Financial LP130,899$3.07M0.0%-2.1%0.280%Search for SEC Filing on Google Icon
2/12/2026Orion Porfolio Solutions LLC9,008$0.21M0.0%-18.2%0.019%Search for SEC Filing on Google Icon
2/12/2026Renaissance Technologies LLC244,300$5.72M0.0%-11.2%0.522%Search for SEC Filing on Google Icon
2/12/2026Annandale Capital LLC60,552$1.42M0.2%-14.2%0.129%Search for SEC Filing on Google Icon
2/12/2026Informed Momentum Co LLC160,412$3.76M0.4%N/A0.343%Search for SEC Filing on Google Icon
2/12/2026New York State Common Retirement Fund12,737$0.30M0.0%+62.5%0.027%Search for SEC Filing on Google Icon
2/12/2026Nuveen LLC302,601$7.09M0.0%-40.4%0.646%Search for SEC Filing on Google Icon
2/11/2026ARK Investment Management LLC121,484$2.85M0.0%-4.1%0.260%Search for SEC Filing on Google Icon
2/11/2026Deutsche Bank AG366,680$8.59M0.0%+126.0%0.783%Search for SEC Filing on Google Icon
2/11/2026Franklin Resources Inc.16,745$0.39M0.0%N/A0.036%Search for SEC Filing on Google Icon
2/11/2026JPMorgan Chase & Co.146,271$3.43M0.0%-72.6%0.312%Search for SEC Filing on Google Icon
2/11/2026WINTON GROUP Ltd13,188$0.31M0.0%N/A0.028%Search for SEC Filing on Google Icon
2/10/2026TD Asset Management Inc80,188$1.88M0.0%+82.2%0.171%Search for SEC Filing on Google Icon
2/10/2026Goldman Sachs Group Inc.459,722$10.77M0.0%+8.2%0.982%Search for SEC Filing on Google Icon
2/10/2026Intech Investment Management LLC22,210$0.52M0.0%+45.9%0.047%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC475,212$11.13M0.0%+0.8%1.015%Search for SEC Filing on Google Icon
2/6/2026ProShare Advisors LLC8,812$0.21M0.0%N/A0.019%Search for SEC Filing on Google Icon
2/5/2026DNB Asset Management AS16,961$0.40M0.0%N/A0.036%Search for SEC Filing on Google Icon
2/3/2026Privium Fund Management B.V.214,622$5.03M0.9%+9.2%0.458%Search for SEC Filing on Google Icon
2/2/2026Oppenheimer & Co. Inc.16,962$0.40M0.0%N/A0.036%Search for SEC Filing on Google Icon
1/29/2026UBS Group AG235,040$5.51M0.0%+30.2%0.502%Search for SEC Filing on Google Icon
1/29/2026China Universal Asset Management Co. Ltd.7,627$0.18M0.0%-5.9%0.016%Search for SEC Filing on Google Icon
1/26/2026Mirae Asset Global Investments Co. Ltd.2,275$53K0.0%+27.2%0.005%Search for SEC Filing on Google Icon
1/23/2026Oak Ridge Investments LLC85,230$2M0.1%-2.6%0.182%Search for SEC Filing on Google Icon
1/14/2026Hennion & Walsh Asset Management Inc.161,924$3.79M0.1%+148.4%0.346%Search for SEC Filing on Google Icon
1/9/2026SG Americas Securities LLC1,377,647$32.26M0.0%+19.0%2.943%Search for SEC Filing on Google Icon
1/1/2026JPMorgan Chase & Co.534,545$10.66M0.0%+36.9%1.142%Search for SEC Filing on Google Icon
11/17/2025Jacobs Levy Equity Management Inc.21,376$0.43M0.0%N/A0.046%Search for SEC Filing on Google Icon
11/17/2025TCG Crossover Management LLC717,347$14.31M0.7%N/A1.532%Search for SEC Filing on Google Icon
11/17/2025XTX Topco Ltd29,302$0.59M0.0%N/A0.063%Search for SEC Filing on Google Icon
11/17/2025Voloridge Investment Management LLC687,475$13.72M0.0%N/A1.469%Search for SEC Filing on Google Icon
11/17/2025Verition Fund Management LLC89,028$1.78M0.0%N/A0.190%Search for SEC Filing on Google Icon
11/17/2025Paradigm Biocapital Advisors LP4,216,084$84.11M2.4%N/A9.007%Search for SEC Filing on Google Icon
11/17/2025Parkman Healthcare Partners LLC402,595$8.03M0.8%+127.8%0.860%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.17,017$0.34M0.0%-15.8%0.036%Search for SEC Filing on Google Icon
11/17/2025HighVista Strategies LLC31,886$0.64M0.2%N/A0.068%Search for SEC Filing on Google Icon
11/17/2025Farallon Capital Management LLC11,000$0.22M0.0%N/A0.023%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE108,454$2.16M0.0%-59.1%0.232%Search for SEC Filing on Google Icon
11/14/2025Creative Planning10,444$0.21M0.0%N/A0.022%Search for SEC Filing on Google Icon
11/14/2025Schonfeld Strategic Advisors LLC297,851$5.94M0.0%+36.3%0.636%Search for SEC Filing on Google Icon
11/14/2025Man Group plc10,780$0.22M0.0%-24.5%0.023%Search for SEC Filing on Google Icon
11/14/2025Orbimed Advisors LLC689,000$13.75M0.3%+44.0%1.472%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP386,203$7.71M0.0%+103.9%0.825%Search for SEC Filing on Google Icon
11/13/2025Jump Financial LLC103,866$2.07M0.0%N/A0.222%Search for SEC Filing on Google Icon
11/13/2025Annandale Capital LLC70,552$1.41M0.2%-6.6%0.151%Search for SEC Filing on Google Icon
11/13/2025UBS Group AG180,460$3.60M0.0%-41.5%0.386%Search for SEC Filing on Google Icon
11/13/2025BNP Paribas Financial Markets308,328$6.15M0.0%+328.7%0.659%Search for SEC Filing on Google Icon
11/13/2025Russell Investments Group Ltd.3,321$66K0.0%+1,594.4%0.007%Search for SEC Filing on Google Icon
11/13/2025Jefferies Financial Group Inc.2,199,652$43.88M0.2%-1.3%4.699%Search for SEC Filing on Google Icon
11/12/2025Barclays PLC55,619$1.11M0.0%-20.7%0.119%Search for SEC Filing on Google Icon
11/12/2025Orion Porfolio Solutions LLC11,008$0.22M0.0%N/A0.024%Search for SEC Filing on Google Icon
11/12/2025HAP Trading LLC19,806$0.27M0.0%N/A0.042%Search for SEC Filing on Google Icon
11/12/2025ARK Investment Management LLC126,720$2.53M0.0%-23.7%0.271%Search for SEC Filing on Google Icon
11/12/2025Intech Investment Management LLC15,227$0.30M0.0%-19.4%0.033%Search for SEC Filing on Google Icon
11/12/2025Fox Run Management L.L.C.16,902$0.34M0.1%N/A0.036%Search for SEC Filing on Google Icon
11/10/2025TD Asset Management Inc44,000$0.88M0.0%-17.6%0.094%Search for SEC Filing on Google Icon
11/10/2025Ameritas Investment Partners Inc.3,082$61K0.0%-19.6%0.007%Search for SEC Filing on Google Icon
11/10/2025China Universal Asset Management Co. Ltd.8,109$0.16M0.0%-12.4%0.017%Search for SEC Filing on Google Icon
11/10/2025Persistent Asset Partners Ltd20,726$0.41M0.3%-40.1%0.044%Search for SEC Filing on Google Icon
11/7/2025NEOS Investment Management LLC50,458$1.01M0.0%N/A0.109%Search for SEC Filing on Google Icon
11/7/2025GSA Capital Partners LLP48,964$0.98M0.1%N/A0.106%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.303,785$6.06M0.0%+19.1%0.657%Search for SEC Filing on Google Icon
11/7/2025JPMorgan Chase & Co.534,545$10.66M0.0%+36.9%1.156%Search for SEC Filing on Google Icon
11/4/2025Allianz Asset Management GmbH22,000$0.44M0.0%+48.6%0.048%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Urogen Pharma logo
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers. It offers RTGel, a novel proprietary polymeric biocompatible, reverse thermal gelation hydrogel technology to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102 for the treatment of several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial cancer and low-grade intermediate risk non-muscle invasive bladder cancer (NMIBC). It is also developing UGN-301 for the treatment of high-grade NMIBC. The company has license agreement with Agenus Inc. to develop, make, use, sell, import, and commercialize products of Agenus for the treatment of cancers of the urinary tract via intravesical delivery; strategic research collaboration agreement with MD Anderson focusing on the sequential use of UGN-201 and UGN-301 for the treatment of NMIBC; and licensing and supply agreement with medac Gesellschaft für klinische Spezialpräparate m.b.H. to develop UGN-103 in low-grade intermediate risk NMIBC and UGN-104 in low-grade upper tract urothelial carcinoma. UroGen Pharma Ltd. was incorporated in 2004 and is based in Princeton, New Jersey.
Read More on Urogen Pharma

Today's Range

Now: $17.90
Low: $17.66
High: $18.16

50 Day Range

MA: $19.94
Low: $17.30
High: $22.27

52 Week Range

Now: $17.90
Low: $3.42
High: $30.00

Volume

322,867 shs

Average Volume

779,568 shs

Market Capitalization

$871.37 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.34

Who are the company insiders with the largest holdings of Urogen Pharma?

Urogen Pharma's top insider investors include:
  1. Elizabeth A Barrett (CEO)
  2. Mark Schoenberg (Insider)
  3. Jason Drew Smith (General Counsel)
  4. Peter P Pfreundschuh (CFO)
  5. Stephen Mullennix (COO)
  6. Molly Henderson (CFO)
  7. Chris Degnan (CFO)
  8. Proquest Investments Iv, LP (Major Shareholder)
Learn More about top insider investors at Urogen Pharma.

Who are the major institutional investors of Urogen Pharma?

Urogen Pharma's top institutional investors include:
  1. Paradigm Biocapital Advisors LP — 9.56%
  2. Morgan Stanley — 5.48%
  3. SG Americas Securities LLC — 2.94%
  4. Healthcare of Ontario Pension Plan Trust Fund — 2.40%
  5. MPM Bioimpact LLC — 2.01%
  6. Orbimed Advisors LLC — 1.87%
Learn More about top institutional investors of Urogen Pharma stock.

Which institutional investors are selling Urogen Pharma stock?

In the last quarter, URGN stock was sold by these institutional investors:
  1. Millennium Management LLC
  2. Tang Capital Management LLC
  3. JPMorgan Chase & Co.
  4. Voloridge Investment Management LLC
  5. Nuveen LLC
  6. Panagora Asset Management Inc.
  7. Jump Financial LLC
  8. Diadema Partners LP
Within the previous year, company insiders that have sold Urogen Pharma company stock include:
  1. Elizabeth A Barrett (CEO)
  2. Mark Schoenberg (Insider)
  3. Jason Drew Smith (General Counsel)
Learn More investors selling Urogen Pharma stock.

Which institutional investors are buying Urogen Pharma stock?

Within the last quarter, URGN stock was purchased by institutional investors including:
  1. Healthcare of Ontario Pension Plan Trust Fund
  2. MPM Bioimpact LLC
  3. Superstring Capital Management LP
  4. Opaleye Management Inc.
  5. Price T Rowe Associates Inc. MD
  6. Paradigm Biocapital Advisors LP
  7. SG Americas Securities LLC
  8. Deutsche Bank AG

Urogen Pharma Active Insiders

Elizabeth A Barrett
Elizabeth A Barrett (Age 62)
CEO
Molly Henderson
Molly Henderson (Age 55)
CFO
Chris Degnan
Chris Degnan (Age 46)
CFO
1 recent trades
Jason Drew Smith
Jason Drew Smith (Age 53)
General Counsel
1 recent trades
Mark Schoenberg
Mark Schoenberg (Age 68)
Insider
2 recent trades